Table 1.
The general information of patients with different CDK1 expression levels. The data for analysis were from the LUAD project in TCGA database.
| Characteristic | Low Expression of CDK1 | High Expression of CDK1 | p |
|---|---|---|---|
| n | 256 | 257 | |
| T stage, n (%) | <0.001 | ||
| T1 | 108 (21.2%) | 60 (11.8%) | |
| T2 | 115 (22.5%) | 161 (31.6%) | |
| T3 | 23 (4.5%) | 24 (4.7%) | |
| T4 | 8 (1.6%) | 11 (2.2%) | |
| N stage, n (%) | <0.001 | ||
| N0 | 184 (36.7%) | 146 (29.1%) | |
| N1 | 34 (6.8%) | 61 (12.2%) | |
| N2 | 29 (5.8%) | 45 (9%) | |
| N3 | 0 (0%) | 2 (0.4%) | |
| M stage, n (%) | 0.023 | ||
| M0 | 171 (46.3%) | 173 (46.9%) | |
| M1 | 6 (1.6%) | 19 (5.1%) | |
| Gender, n (%) | 0.009 | ||
| Female | 153 (29.8%) | 123 (24%) | |
| Male | 103 (20.1%) | 134 (26.1%) | |
| Race, n (%) | 0.967 | ||
| Asian | 4 (0.9%) | 3 (0.7%) | |
| Black or African American | 28 (6.3%) | 24 (5.4%) | |
| White | 200 (44.8%) | 187 (41.9%) | |
| Age, n (%) | 0.151 | ||
| ≤65 | 111 (22.5%) | 127 (25.7%) | |
| >65 | 137 (27.7%) | 119 (24.1%) | |
| Smoker, n (%) | 0.105 | ||
| No | 44 (8.8%) | 30 (6%) | |
| Yes | 206 (41.3%) | 219 (43.9%) |